SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter ...

Wearables are big news this year, from headsets to smart rings but Lingo offers something that most devices can’t. The Lingo biosensor is a continuous glucose monitor that reads your body’s blood ...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the FDA has cleared Stelo by Dexcom ...

Credit: Dexcom. Stelo is an integrated CGM that continuously measures, records, analyzes, and displays glucose values in individuals 18 years of age and older who are not on insulin. Dexcom’s Stelo ...

An over-the-counter continuous glucose monitoring (CGM) solution developed by Dexcom called Stelo has received clearance from the Food and Drug Administration (FDA). Available without the need for a ...

Developing an alternative approach to blood glucose monitoring that does not rely on lancets and pinpricks has been a primary goal of diabetes device R&D in recent years. Contributing to this effort, ...

DexCom Inc. DXCM recently announced the FDA clearance of its Stelo glucose biosensor, available over-the-counter to consumers without a prescription. The company’s latest Continuous Glucose Monitoring ...

San Diego’s Dexcom began sales this week of Stelo, the industry’s first FDA-approved continuous glucose monitor that doesn’t require a prescription. With a two-pack of the biosensor costing just under ...

You don't need to wait for Apple to add glucose sensing to a smartwatch. Biosensors give you real-time data, and you no longer require a prescription. Jessica was a writer on the Wellness team, with a ...

Home-based continuous glucose monitoring for diabetics up to now has had to trade ease of use, low cost, and portability for a somewhat lower sensitivity - and thus accuracy - compared to similar ...